Helus Pharma director reports 19,737 warrants

The reported warrant position has a US$17.37 exercise price and an August 20, 2030 expiration date.

Rhea-AI Filing Summary

Helus Pharma Inc. (HELP) director Grant Froese reported ownership positions as of October 13, 2026, including 19,737 directly held warrants tied to 19,737 underlying common shares. The warrants have a US$17.37 exercise price and expire August 20, 2030. The exercise price reflects conversion from C$24.32 at C$1.4 = US$1.00. Froese also reported 156,000 common shares held by Greywolf Management Services Inc., which he owns and controls, and 5,263 common shares held by his spouse.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Froese Grant

Role Director

Type	Security	Shares	Price	Value
holding	Warrants F2	--	--	--
holding	Common Shares	--	--	--
holding	Common Shares F1	--	--	--

Holdings After Transaction: Warrants — 19,737 contracts (Direct); Common Shares — 5,263 shares (Indirect, Held by spouse); Common Shares — 156,000 shares (Indirect, Held by Greywolf Management Services Inc.)

Footnotes (2)

1. F1. Held by Greywolf Management Services Inc., a corporation owned and controlled by the reporting person.
2. F2. Converted from Canadian exercise price of C$24.32 using an exchange rate of C$1.4 = US$1.00.

Key Figures

Directly held warrants: 19,737 warrants Underlying common shares: 19,737 shares Common shares held by Greywolf Management Services Inc.: 156,000 shares +3 more

6 metrics

Directly held warrants 19,737 warrants Reported as of October 13, 2026

Underlying common shares 19,737 shares Underlying the directly held warrants

Common shares held by Greywolf Management Services Inc. 156,000 shares The corporation is owned and controlled by Grant Froese

Common shares held by spouse 5,263 shares Reported as of October 13, 2026

Warrant exercise price US$17.37 per share Converted from C$24.32 using C$1.4 = US$1.00

Warrant expiration date August 20, 2030 Directly held warrants

Key Terms

Warrants, exercise price, exchange rate

3 terms

Warrants financial

"Warrants"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

exercise price financial

"Canadian exercise price of C$24.32"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

exchange rate financial

"using an exchange rate of C$1.4 = US$1.00"

Exchange rate is the price of one currency expressed in another—for example, how many euros you receive for one US dollar. It matters to investors because changes in that price alter the reported profits, costs and value of assets for companies and portfolios that operate or hold money across borders; think of it like switching measurement units, where the same item can look bigger or smaller depending on the unit used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What shares and warrants did HELP director Grant Froese report?

Grant Froese reported 19,737 directly held warrants tied to 19,737 underlying common shares, 156,000 common shares held by Greywolf Management Services Inc., and 5,263 common shares held by his spouse.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/23/2026 - 07:19 PM EDT Accepted by SEC EDGAR 10/23/2026 - 07:19 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Froese Grant

(Last) (First) (Middle)

C/O HELUS PHARMA INC.

100 KING STREET W., SUITE 5600

(Street)

TORONTO M5X 1C9

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
10/13/2026

3. Issuer Name and Ticker or Trading Symbol
Helus Pharma Inc. [ HELP ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	5,263	I	Held by spouse
Common Shares	156,000	I	Held by Greywolf Management Services Inc.(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants	11/05/2020	08/20/2030	Common Shares	19,737	$17.37(2)	D

Explanation of Responses:

1. Held by Greywolf Management Services Inc., a corporation owned and controlled by the reporting person.

2. Converted from Canadian exercise price of C$24.32 using an exchange rate of C$1.4 = US$1.00.

	/s/ Grant Froese	10/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)